Megakaryocytic emperipolesis in the rat bone marrow induced by lipopolysaccharide

M Tanaka1, Y Aze, T Fujita

  • 1Fukui Institute for Safety Research, ONO Pharmaceutical Co., Ltd., Japan.

Insights

Lipopolysaccharide (LPS) administration in rats increased megakaryocytic emperipolesis, a process where cells engulf others. This phenomenon correlated with a significant decrease in peripheral platelet counts.

Area of Science:

  • Hematology
  • Cell Biology
  • Immunology

Background:

  • Megakaryocytes are crucial for platelet production in bone marrow.
  • Emperipolesis is a poorly understood cellular interaction within the bone marrow.
  • Lipopolysaccharide (LPS) is a potent immune stimulant.

Purpose of the Study:

  • To investigate the effect of lipopolysaccharide (LPS) on megakaryocytic emperipolesis in rats.
  • To determine the relationship between emperipolesis and platelet counts.

Main Methods:

  • Rats were administered LPS intravenously (0.5 mg/kg/day) for 4 weeks.
  • Bone marrow and peripheral blood were analyzed for megakaryocytes, emperipolesis, and platelet counts.
  • Histological and morphological assessments were performed.

Main Results:

  • LPS treatment significantly increased megakaryocytic emperipolesis from 1.35% to 3.54%.
  • Hematocytes were engulfed by megakaryocytes without apparent cellular damage.
  • Peripheral platelet counts were markedly reduced in LPS-treated rats (63.7 x 10^4/mm^3) compared to controls (128.4 x 10^4/mm^3).
  • Megakaryocytes exhibiting emperipolesis were predominantly mature, suggesting high platelet production capacity.

Conclusions:

  • LPS induces significant megakaryocytic emperipolesis in rat bone marrow.
  • Emperipolesis is closely associated with a marked reduction in peripheral platelet counts.
  • The findings suggest a complex interplay between emperipolesis, megakaryocyte maturation, and platelet homeostasis.

Related Concept Videos